APA (7th ed.) Citation

Bu, J., Li, Z., Hu, D., Lan, L., Huang, J., Wang, X., . . . Zeng, Y. Enhanced efficacy of immune checkpoint inhibitors combined locoregional therapy and tyrosine kinase inhibitors in the treatment of unresectable hepatocellular carcinoma: A single - center retrospective study. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Bu, Junfeng, Zihan Li, Die Hu, Ling Lan, Jiwei Huang, Xin Wang, Qiu Li, Jin Zhou, and Yong Zeng. Enhanced Efficacy of Immune Checkpoint Inhibitors Combined Locoregional Therapy and Tyrosine Kinase Inhibitors in the Treatment of Unresectable Hepatocellular Carcinoma: A Single - Center Retrospective Study. Frontiers Media S.A.

MLA (9th ed.) Citation

Bu, Junfeng, et al. Enhanced Efficacy of Immune Checkpoint Inhibitors Combined Locoregional Therapy and Tyrosine Kinase Inhibitors in the Treatment of Unresectable Hepatocellular Carcinoma: A Single - Center Retrospective Study. Frontiers Media S.A.